5KGX | pdb_00005kgx

HIV1 catalytic core domain in complex with an inhibitor (2~{S})-2-[3-(3,4-dihydro-2~{H}-chromen-6-yl)-1-methyl-indol-2-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.67 Å
  • R-Value Free: 
    0.244 (Depositor), 0.249 (DCC) 
  • R-Value Work: 
    0.191 (Depositor), 0.198 (DCC) 

wwPDB Validation 3D Report Full Report

Validation slider image for 5KGX

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Indole-based allosteric inhibitors of HIV-1 integrase.

Patel, P.A.Kvaratskhelia, N.Mansour, Y.Antwi, J.Feng, L.Koneru, P.Kobe, M.J.Jena, N.Shi, G.Mohamed, M.S.Li, C.Kessl, J.J.Fuchs, J.R.

(2016) Bioorg Med Chem Lett 26: 4748-4752

  • DOI: https://doi.org/10.1016/j.bmcl.2016.08.037
  • Primary Citation Related Structures: 
    5KGW, 5KGX

  • PubMed Abstract: 

    Employing a scaffold hopping approach, a series of allosteric HIV-1 integrase (IN) inhibitors (ALLINIs) have been synthesized based on an indole scaffold. These compounds incorporate the key elements utilized in quinoline-based ALLINIs for binding to the IN dimer interface at the principal LEDGF/p75 binding pocket. The most potent of these compounds displayed good activity in the LEDGF/p75 dependent integration assay (IC50=4.5μM) and, as predicted based on the geometry of the five- versus six-membered ring, retained activity against the A128T IN mutant that confers resistance to many quinoline-based ALLINIs.


  • Organizational Affiliation
    • Division of Medicinal Chemistry & Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, United States; Department of Chemistry, The Ohio State University, Columbus, OH 43210, United States.

Macromolecule Content 

  • Total Structure Weight: 18.67 kDa 
  • Atom Count: 1,112 
  • Modeled Residue Count: 136 
  • Deposited Residue Count: 163 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Integrase163Human immunodeficiency virus 1Mutation(s): 2 
UniProt
Find proteins for P12497 (Human immunodeficiency virus type 1 group M subtype B (isolate NY5))
Explore P12497 
Go to UniProtKB:  P12497
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP12497
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
7SK

Query on 7SK



Download:Ideal Coordinates CCD File
B [auth A](2S)-tert-butoxy[3-(3,4-dihydro-2H-1-benzopyran-6-yl)-1-methyl-1H-indol-2-yl]acetic acid
C24 H27 N O4
JEETZBQOULTRJG-QFIPXVFZSA-N
SO4

Query on SO4



Download:Ideal Coordinates CCD File
C [auth A]SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
Modified Residues  1 Unique
IDChains TypeFormula2D DiagramParent
CAF
Query on CAF
A
L-PEPTIDE LINKINGC5 H12 As N O3 SCYS

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.67 Å
  • R-Value Free:  0.244 (Depositor), 0.249 (DCC) 
  • R-Value Work:  0.191 (Depositor), 0.198 (DCC) 
Space Group: P 31 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 72.109α = 90
b = 72.109β = 90
c = 65.713γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement
HKL-3000data reduction
SCALEPACKdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2016-10-19
    Type: Initial release
  • Version 1.1: 2016-11-02
    Changes: Non-polymer description
  • Version 1.2: 2018-03-07
    Changes: Data collection, Derived calculations
  • Version 1.3: 2024-11-13
    Changes: Data collection, Database references, Structure summary